Harvard researcher Dr. David Sinclair has found himself at the center of controversy within the longevity community. Sinclair has been a poster child of the longevity movement for years.
Harvard geneticist David Sinclair’s seductive notion that aging is a treatable disease has helped companies he founded to raise more than $1 billion. The investors have almost nothing to show ...
Sinclair, from Harvard Medical School, is testing a pill that appears to address and even reverse some of the typical signs of aging, including higher blood pressure, weight gain and slower ...
In March 2013, a group of 40 scientists from Harvard Medical School were invited by biologist David Sinclair to the dining ... where he is a professor of genetics, and Sydney, where he heads ...